sickle cell disease

WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and... Read More

WASHINGTON — A new Senate bill, the Sickle Cell Care Expansion Act, would provide educational incentives and create competitive grants to help grow the number of health care workers trained to care for sickle cell disease patients. The lead sponsor... Read More